Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.56 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.56 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.56 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.56 |
| ▸ | SLC6A1 | P30531 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7813228 | 1.00 | CHRNB2 (0.56) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8202527 | 0.89 | CHRNB2 (0.52) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8206721 | 0.88 | SLC6A1 (0.61) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8202612 | 0.88 | SLC6A1 (0.61) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8202368 | 0.87 | SLC6A1 (0.57) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8203622 | 0.87 | CHRNB2 (0.47) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8203132 | 0.87 | SLC6A1 (0.61) | SLC6A1CYP2D6 | |
| SCHEMBL8206888 | 0.85 | SLC6A1 (0.61) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL8206144 | 0.85 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 | |
| SCHEMBL7843283 | 0.84 | SLC6A1 (0.52) | CHRNB2CHRNB4CHRNA3CHRNA4SLC6A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0869954-B1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF NEUROGENIC INFLAMMATION | NOVO NORDISK AS (DK) | 2001-09-19 | — | — | EP | claimed |